Aurinia Pharmaceuticals Inc (AUPH)

[northern vortex]

It's hard to tell what their price target is based on without seeing their research report. I would expect that it reflects the next known catalyst, which will most likely be robust sales numbers.

We have to let the crackerjack sales team go to work. A real kicker would be if any of the sales are for off-label purposes. That would add real sizzle to the steak.